A patent review of RAF kinase inhibitors (2010-2018).

Man, Ruo-Jun; Zhang, Ya-Liang; Jiang, Ai-Qin; Zhu, Hai-Liang

Man, Ruo-Jun; Zhang, Ya-Liang; Jiang, Ai-Qin; Zhu, Hai-Liang.

Affiliation

Man RJ; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University , Nanjing , People's Republic of China.
Zhang YL; College of Chemistry and Chemical Engineering, Guangxi University for Nationalities , Nanning , People's Republic of China.
Jiang AQ; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University , Nanjing , People's Republic of China.
Zhu HL; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University , Nanjing , People's Republic of China.

Expert Opin Ther Pat ; 29(9): 675-688, 2019 Sep.

Article in En | MEDLINE | ID: mdl-31370713

Subject(s)

Antineoplastic Agents/pharmacology; Neoplasms/drug therapy; raf Kinases/antagonists & inhibitors; Animals; Drug Development/methods; Drug Resistance, Neoplasm; Humans; Molecular Targeted Therapy; Neoplasms/enzymology; Patents as Topic; Protein Kinase Inhibitors/pharmacology; Signal Transduction/drug effects; raf Kinases/metabolism

Key words

RAF kinase inhibitors; anti-tumor; chemical structure; classification

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Raf Kinases / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Expert Opin Ther Pat Journal subject: TERAPEUTICA Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google